Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1435 | 1082 | 1658 | 1952 | 4053 | - |
Fund Return | 43.49% | 8.22% | 65.82% | 24.97% | 32.3% | - |
Place in category | 7 | 45 | 4 | 4 | 4 | - |
% in Category | 6 | 42 | 3 | 4 | 6 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ICICI Focused Bluechip Equity RetGr | 636.7B | 19.57 | 17.19 | 14.12 | ||
ICICI Focused Bluechip Eq RetailDiv | 636.7B | 18.88 | 16.39 | 13.30 | ||
ICICI Prud Focused Bluechip Div | 636.7B | 19.95 | 17.65 | 14.65 | ||
ICICI Prud Focused Bluechip Gr | 636.7B | 20.15 | 17.90 | 14.99 | ||
ICICI Balanced Adv Dir Div | 605.45B | 13.16 | 12.53 | 11.67 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 86.89B | 30.90 | 19.84 | 15.52 | ||
Reliance Pharma Dividend Payout | 86.89B | 29.93 | 21.25 | 16.57 | ||
Reliance Pharma Fund - Growth | 86.89B | 30.90 | 19.84 | 15.52 | ||
Reliance Pharma Direct Bonus | 86.89B | 31.89 | 20.92 | 16.54 | ||
Reliance Pharma Direct Growth | 86.89B | 31.89 | 20.92 | 16.54 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Sun Pharma | INE044A01036 | 14.35 | 1,795.30 | +0.86% | |
Dr Reddy’s Laboratories | INE089A01031 | 9.03 | 1,214.45 | +1.60% | |
Cipla | INE059A01026 | 8.07 | 1,486.50 | +1.43% | |
Lupin | INE326A01037 | 4.59 | 2,071.35 | +1.39% | |
Aurobindo Pharma | INE406A01037 | 4.57 | 1,223.70 | +0.30% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Strong Buy |
Technical Indicators | Strong Sell | Neutral | Strong Buy |
Summary | Neutral | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review